Valvular heart disease (VHD) is a major contributor to loss of physical function, quality of life
and longevity. The epidemiology of VHD varies substantially around the world, with a …

Background Transcatheter aortic valve implantation/replacement (TAVI/TAVR) is becoming
more frequently used to treat aortic stenosis (AS), with increasing push for the procedure in …

Aims To assess the contemporary trends in aortic stenosis (AS) interventions in the USA
before and after the introduction of transcatheter aortic valve implantation (TAVI). Methods …

In Europe, approximately one million people over 75 years suffer from severe aortic stenosis
(AS), one of the most serious and most common valve diseases, and this disease burden is …

Medical devices (MDs) have distinctive features, such as incremental innovation, dynamic
pricing, the learning curve and organisational impact, that need to be considered when they …

Background Transcatheter edge-to-edge mitral valve repair (TMVr) improves symptoms and
survival for patients with heart failure with reduced left ventricular ejection fraction (HFrEF) …

De COVID-19-epidemie heeft tijdens de eerste golf grote impact gehad op de zorg, vooral in
het voorjaar van 2020. Afspraken, behandelingen en operaties voor niet-COVID-patiënten …

Aortic stenosis (AS) is a progressive disease that carries a poor prognosis. Patients are
managed conservatively until satisfying an indication for transcatheter aortic valve …

Multiple guidelines exist for the management of aortic stenosis (AS). We systematically
reviewed current guidelines and recommendations, developed by national or international …

Objective The scope of this systematic review is to update the existing body of evidence
regarding the cost-effectiveness of transcatheter aortic valve implantation, stratified across …